EW Share Price Performance
US$86.82
15.27 (21.34%)
7.6% undervalued intrinsic discount
US$93.94
Fair Value
Price US$86.82
AnalystConsensusTarget US$93.94
Fair ValueUS$93.94
Share Pricen/a
Edwards Lifesciences Corporation Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 62 Fair Values set on narratives written by author
EW Community Narratives
AN
Fair Value US$93.94 7.6% undervalued intrinsic discount
Durability Data And Real-World Evidence Will Shape Risk And Opportunity Ahead
0users have liked this narrative
0users have commented on this narrative
26users have followed this narrative
Durability Data And Real-World Evidence Will Shape Risk And Opportunity Ahead
Key Takeaways Strategic product launches, like the TAVR approval and EVOQUE, position Edwards for significant revenue growth and expanded market share. Investments in surgical innovation and operational efficiency mitigate financial threats, enhance global therapy adoption, and stabilize earnings.Read more
0users have liked this narrative
0users have commented on this narrative
26users have followed this narrative
AN
US$93.94
7.6% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
9.88% p.a.
Profit Margin
24.03%
Future PE
34.57x
Share price in 2028
US$117.3
Recently Updated Narratives
AN
Durability Data And Real-World Evidence Will Shape Risk And Opportunity Ahead
Fair Value: US$93.94 7.6% undervalued intrinsic discount
26 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Edwards Lifesciences Corporation Key Details
About EW
- Founded
- 1958
- Employees
- 15800
- CEO
- WebsiteView website
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
